CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- 4 Planned sale CHIEF ACCOUNTING OFFICER sold 16,670 shares at $19.17 ($319,564)
- 8-K Event Results of operations · Regulation FD disclosure
- 144 Insider Sale of Securities
- UPLOAD Other SEC-generated Letter
- 4 Planned sale CHIEF ACCOUNTING OFFICER sold 9,316 shares at $19.13 ($178,215)
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF MEDICAL OFFICER sold 28,600 shares at an average $17.65 ($504,758)
- CORRESP Other Correspondence Between Filers and SEC Staff
- 144 Insider Sale of Securities
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 4 Option exercise Director acquired 2,777 shares (option exercise)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Shares withheld for taxes CHIEF ACCOUNTING OFFICER gave up 52 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF ACCOUNTING OFFICER gave up 1,383 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF COMMERCIAL OFFICER gave up 1,896 shares (to pay taxes)
- 4 Shares withheld for taxes CHAIRMAN & CEO gave up 6,619 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 1,338 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF OPERATING OFFICER gave up 1,378 shares (to pay taxes)
Page 20 of 39 · 778 filings